Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
775.4 USD | -0.73% | +5.87% | +32.98% |
05:58pm | Amgen investors await weight-loss drug data | RE |
05:38pm | Danish Medicines Agency Says Type 2 Diabetes Patients Should Start Treatment With 'Cheaper' Drugs | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.98% | 704B | |
+28.59% | 577B | |
-3.69% | 348B | |
+18.38% | 327B | |
+5.60% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.01% | 147B | |
-6.93% | 145B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly's Phase 3 Trials of Tirzepatide to Treat Sleep Apnea Meet Endpoints